Fiduciary Trust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.32M Sell
109,315
-2,132
-2% -$190K 0.11% 113
2025
Q4
$8.81M Sell
111,447
-7,324
-6% -$574K 0.1% 118
2025
Q3
$9.49M Sell
118,771
-5,337
-4% -$455K 0.11% 117
2025
Q2
$11.3M Sell
124,108
-3,958
-3% -$361K 0.14% 97
2025
Q1
$12M Sell
128,066
-10,452
-8% -$936K 0.16% 94
2024
Q4
$12.6M Buy
138,518
+2,675
+2% +$255K 0.17% 90
2024
Q3
$14.1M Sell
135,843
-1,417
-1% -$144K 0.2% 81
2024
Q2
$13.3M Sell
137,260
-214
-0.2% -$19.7K 0.2% 74
2024
Q1
$12.4M Buy
137,474
+224
+0.2% +$19K 0.19% 85
2023
Q4
$10.9M Sell
137,250
-7,630
-5% -$574K 0.18% 92
2023
Q3
$10.3M Sell
144,880
-1,497
-1% -$112K 0.19% 87
2023
Q2
$11.3M Buy
146,377
+4,121
+3% +$319K 0.2% 89
2023
Q1
$10.7M Sell
142,256
-512
-0.4% -$38.1K 0.2% 88
2022
Q4
$11.2M Sell
142,768
-824
-0.6% -$61.8K 0.22% 84
2022
Q3
$10.1M Sell
143,592
-37
-0% -$2.9K 0.22% 82
2022
Q2
$11.5M Sell
143,629
-2,671
-2% -$209K 0.24% 85
2022
Q1
$11.1M Sell
146,300
-5,036
-3% -$399K 0.2% 100
2021
Q4
$12.9M Sell
151,336
-15,356
-9% -$1.2M 0.21% 90
2021
Q3
$12.6M Sell
166,692
-5,840
-3% -$464K 0.22% 88
2021
Q2
$14M Sell
172,532
-20,679
-11% -$1.69M 0.27% 78
2021
Q1
$15.2M Sell
193,211
-4,292
-2% -$336K 0.31% 66
2020
Q4
$16.9M Buy
197,503
+5,500
+3% +$455K 0.35% 58
2020
Q3
$14.8M Buy
192,003
+2,564
+1% +$195K 0.35% 59
2020
Q2
$13.9M Sell
189,439
-4,111
-2% -$292K 0.34% 62
2020
Q1
$12.8M Buy
193,550
+4,998
+3% +$352K 0.37% 63
2019
Q4
$13M Sell
188,552
-2,268
-1% -$155K 0.3% 72
2019
Q3
$14M Sell
190,820
-1,590
-0.8% -$115K 0.35% 67
2019
Q2
$13.8M Sell
192,410
-2,772
-1% -$197K 0.36% 62
2019
Q1
$13.4M Sell
195,182
-12,080
-6% -$780K 0.36% 66
2018
Q4
$12.3M Sell
207,262
-4,964
-2% -$311K 0.38% 63
2018
Q3
$14.2M Buy
212,226
+5,963
+3% +$397K 0.4% 64
2018
Q2
$13.4M Buy
206,263
+1,916
+0.9% +$125K 0.4% 66
2018
Q1
$14.6M Buy
204,347
+45,445
+29% +$3.27M 0.45% 62
2017
Q4
$12M Sell
158,902
-5,193
-3% -$379K 0.36% 74
2017
Q3
$12M Sell
164,095
-6,723
-4% -$485K 0.37% 70
2017
Q2
$12.7M Buy
170,818
+2,758
+2% +$205K 0.39% 71
2017
Q1
$12.3M Sell
168,060
-9,964
-6% -$697K 0.38% 71
2016
Q4
$11.7M Sell
178,024
-3,252
-2% -$223K 0.38% 69
2016
Q3
$13.4M Sell
181,276
-3,498
-2% -$259K 0.46% 63
2016
Q2
$13.5M Sell
184,774
-5,370
-3% -$382K 0.48% 65
2016
Q1
$13.4M Sell
190,144
-371
-0.2% -$24.7K 0.48% 61
2015
Q4
$12.7M Sell
190,515
-4,948
-3% -$329K 0.54% 56
2015
Q3
$12.4M Sell
195,463
-17,289
-8% -$1.13M 0.56% 53
2015
Q2
$13.9M Sell
212,752
-3,665
-2% -$249K 0.58% 53
2015
Q1
$15M Sell
216,417
-1,317
-0.6% -$91K 0.62% 52
2014
Q4
$15.1M Sell
217,734
-1,432
-0.7% -$96.7K 0.63% 50
2014
Q3
$14.3M Sell
219,166
-9,629
-4% -$635K 0.63% 53
2014
Q2
$15.6M Buy
228,795
+387
+0.2% +$25.9K 0.67% 53
2014
Q1
$14.8M Sell
228,408
-5,087
-2% -$321K 0.66% 53
2013
Q4
$15.2M Sell
233,495
-2,829
-1% -$181K 0.67% 51
2013
Q3
$14M Sell
236,324
-12,441
-5% -$737K 0.65% 51
2013
Q2
$14.3M Buy
+248,765
New +$14.8M 0.66% 49

Other funds holding CL

Fiduciary Trust's CL Position: Q1 2026 in Review

Fiduciary Trust reduced its Colgate-Palmolive (CL) stake by 1.9% in Q1 2026, selling an estimated $190K and leaving 109,315 shares worth $9.32M. The position accounts for 0.11% of the portfolio, ranked #113.

Fiduciary Trust first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.9M in Q4 2020. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Fiduciary Trust held 109,315 shares of Colgate-Palmolive worth $9.32M as of Q1 2026.
  • Fiduciary Trust sold 2,132 Colgate-Palmolive shares in Q1 2026, an estimated $190K.
  • Colgate-Palmolive made up 0.11% of Fiduciary Trust's portfolio in Q1 2026, its #113 holding.
  • Fiduciary Trust first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Fiduciary Trust's Colgate-Palmolive position peaked at $16.9M in Q4 2020.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.